Copyright
©The Author(s) 2016.
World J Gastroenterol. Sep 28, 2016; 22(36): 8123-8136
Published online Sep 28, 2016. doi: 10.3748/wjg.v22.i36.8123
Published online Sep 28, 2016. doi: 10.3748/wjg.v22.i36.8123
Country | India[9] | South East Asia[81,82] | Australia[81,82] | |||
Factors | UC | CD | UC | CD | UC | CD |
Median Age (yr) | 38.5 | 35.9 | 42 | 34 | 42 | 34 |
Sex (M: F) | 1.4:1 | 1.3:1 | 1.4:1 | 1.6:1 | 1:1.2 | 1:1.1 |
Smokers | 21.3% | 24.2% | 6% | 11% | 8% | 10% |
Disease location | ||||||
L1 | 28.9% | 31% | 31% | |||
L2 | 31.4% | 24% | 24% | |||
L3 | 39.6% | 45% | 45% | |||
L4 | 5.8% | 5% | 5% | |||
Disease behaviour | ||||||
B1 | 76.8% | 66% | 88% | |||
B2 | 18.8% | 17% | 10% | |||
B3 | 4.4% | 19% | 2% | |||
Perianal | 6.9% | 18% | 12% | |||
Disease extent | ||||||
Proctitis | 18.3% | 37% | 32% | |||
Distal colitis | 38.8% | 32% | 27% | |||
Extensive colitis | 42.8% | 31% | 41% | |||
Treatment | ||||||
5ASA | 89.7% | 58.4% | 68% | 49% | 86% | 71% |
Corticosteroids | 29.1% | 26.9% | 21% | 42% | 50% | 67% |
Immunosuppressive | 29.8% | 62.9% | 8% | 35% | 0 | 14% |
Biologics | 0 | 2.2% | 1% | 5% | 0 | 0 |
Antibiotic | 0 | 0 | 25% | 19% | 0 | 21% |
Probiotics | 6.1% | 7.6% | ||||
Surgery | 4.0% | 15.2% | 1.6% | 11.6% | 5.9% | 14.3% |
Positive family history (%) | 2.3% | 4.6% | 31% | 17%1 | ||
EIM | ||||||
Joints | 33.3% | 26.3% | 13%1 | 3.6%1 | ||
Backache | 31.5% | 36.4% | 3.3[AS]1 | |||
Skin | 2.4% | 3.4% | 4.8%1 | 3.6%1 | ||
Incidence per 105 population | 6.07%[8] | 0.76% | 0.54% | 7.33% | 14% |
- Citation: Ray G. Inflammatory bowel disease in India - Past, present and future. World J Gastroenterol 2016; 22(36): 8123-8136
- URL: https://www.wjgnet.com/1007-9327/full/v22/i36/8123.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i36.8123